Isoprostane as a promising biomarker in pulmonary arterial hypertension: Preanalytical and analytical viewpoints. Response to letter to the editor

被引：1
|
作者：
Zhang, Rui [1 ]
Jing, Zhi-Cheng [2 ,3 ]
机构：
[1] Tongji Univ, Sch Med, Shanghai Pulm Hosp, Dept Cardiopulm Circulat, Shanghai 200092, Peoples R China
[2] Peking Union Med Coll, Thrombosis & Vasc Med Ctr, State Key Lab Cardiovasc Dis, Fu Wai Hosp, Beijing 100021, Peoples R China
[3] Chinese Acad Med Sci, Beijing 100730, Peoples R China
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2014年 / 177卷 / 02期
关键词：
15-F2t-IsoP; Idiopathic pulmonary arterial hypertension; Prognosis; Biomarkers; Preanalytical and analytical; MASS-SPECTROMETRY; PLASMA SAMPLES; F-2-ISOPROSTANES; QUANTIFICATION; 15-F-2T-ISOPROSTANE; STRESS; URINE;
D O I：
10.1016/j.ijcard.2014.09.122
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：632 / 633
页数：2
相关论文
共 38 条
  • [21] Response to Letter Regarding Article, "Circulating Endothelial Progenitor Cells in Patients With Eisenmenger Syndrome and Idiopathic Pulmonary Arterial Hypertension"
    Diller, Gerhard-Paul
    Bedard, Elisabeth
    Wort, Stephen J.
    Gatzoulis, Michael A.
    van Eijl, Sven
    Ali, Omar
    Wilkins, Martin R.
    Wharton, John
    Okonko, Darlington O.
    Howard, Luke S.
    Thum, Thomas
    Bauersachs, Johann
    Gibbs, J. Simon R.
    Hobbs, Adrian J.
    CIRCULATION, 2009, 119 (09) : E231 - E231
  • [22] Response to Letter Regarding Article, "Elevated Levels of Inflammatory Cytokines Predict Survival in Idiopathic and Familial Pulmonary Arterial Hypertension"
    Soon, Elaine
    Morrell, Nicholas W.
    Pepke-Zaba, Joanna
    Treacy, Carmen M.
    Doughty, Natalie J.
    Holmes, Alan M.
    Jennings, Simon
    Barker, Lucy
    Nicklin, Paul
    Walker, Christoph
    Budd, David C.
    Southgate, Laura
    Machado, Rajiv D.
    Trembath, Richard C.
    CIRCULATION, 2011, 123 (21) : E615 - E615
  • [23] Response by Fujisawa et al to Letter Regarding Article, "Pulmonary Artery Denervation by Determining Targeted Ablation Sites for Treatment of Pulmonary Arterial Hypertension"
    Fujisawa, Taishi
    Kataoka, Masaharu
    Kawakami, Takashi
    Isobe, Sarasa
    Nakajima, Kazuaki
    Kunitomi, Akira
    Kashimura, Shin
    Katsumata, Yoshinori
    Nishiyama, Takahiko
    Kimura, Takehiro
    Nishiyama, Nobuhiro
    Aizawa, Yoshiyasu
    Murata, Mitsushige
    Fukuda, Keiichi
    Takatsuki, Seiji
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2018, 11 (02)
  • [24] Response to letter "Clinical characteristics and survival of pulmonary arterial hypertension associated with three major connective tissue diseases: Methodological issues"
    Zhao, Jiuliang
    Wang, Yanhong
    Wang, Qian
    Li, Mengtao
    Zeng, Xiaofeng
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 249 : 418 - 418
  • [25] Response by Mendes-Ferreira et al to Letter Regarding Article, "Bmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Arterial Hypertension"
    Mendes-Ferreira, Pedro
    Manaud, Gregoire
    Perros, Frederic
    CIRCULATION, 2019, 140 (07) : E288 - E289
  • [26] Evaluation of N-Terminal Pro-B-type Natriuretic Peptide as a Therapeutic Response Biomarker in Group I Pulmonary Arterial Hypertension
    Wolfson, Aaron M.
    Maitland, Micheal L.
    Thomeas, Vasiliki
    Glassner, Cherylanne
    Gomberg-Maitland, Mardi
    CIRCULATION, 2014, 130
  • [27] Response by Hoeper et al to Letter Regarding Article, "Randomized, Multicenter Study to Assess the Effects of Different Doses of Sildenafil on Mortality in Adults with Pulmonary Arterial Hypertension"
    Hoeper, Marius M.
    Haughie, Scott
    Hassan, Tarek
    Vogt, Susanne
    Hackley, Sarah
    CIRCULATION, 2025, 151 (04) : e32 - e32
  • [28] Response to Letter Regarding Article, "Hemodynamic, Functional, and Clinical Responses to Pulmonary Artery Denervation in Patients With Pulmonary Arterial Hypertension of Different Causes: Phase II Results From the Pulmonary Artery Denervation-1 Study"
    Chen, Shao-Liang
    Zhang, Hang
    Xie, Du-Jiang
    Zhang, Juan
    Zhou, Ling
    Rothman, Alexander M. K.
    Stone, Gregg W.
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2016, 9 (01) : E3463 - E3463
  • [29] Hemodynamic Dose-Response To Parenteral Treprostinil Occurs At Low Dose And Is Poorly Related To Biomarker And Functional Improvements In Patients With Advanced Treatment Naive Pulmonary Arterial Hypertension
    Hansen, L.
    Rischard, F.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [30] Response to letter by Wang Q et al. regarding article "Serum soluble ST2 and interleukin-33 levels in patients with pulmonary arterial hypertension"
    Carlomagno, Guido
    Fazio, Serafino
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (03) : 3122 - 3122
1234